LABU holdings
Direxion Daily S&P Biotech Bull 3X ETF
Positions
163 stored of 163 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DREYFUS DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) | Not reported | Not reported | 15.856% | $78.4M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 2 | GOLDMAN FINANCIAL GOLDMAN FINL SQ TRSRY INST 506 | Not reported | Not reported | 14.827% | $73.3M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 3 | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Not reported | Not reported | 9.628% | $47.6M | Other derivatives | Other | United States | USD |
| 4 | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Not reported | Not reported | 7.296% | $36.1M | Other derivatives | Other | United States | USD |
| 5 | GOLDMAN SACHS LIQ ES FD A GOLDMAN SACHS FIN GOV 465 INSTITUT | Not reported | Not reported | 5.355% | $26.5M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 6 | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Not reported | Not reported | 4.847% | $24.0M | Other derivatives | Other | United States | USD |
| 7 | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Not reported | Not reported | 3.874% | $19.2M | Other derivatives | Other | United States | USD |
| 8 | APOGEE THERAPEUTICS INC | US03770N1019 | 03770N101 | 1.107% | $5.5M | Equity (common) | Corporate | United States | USD |
| 9 | ORUKA THERAPEUTICS INC | US6876041087 | 687604108 | 1.029% | $5.1M | Equity (common) | Corporate | United States | USD |
| 10 | DIANTHUS THERAPEUTICS INC | US2528281080 | 252828108 | 0.955% | $4.7M | Equity (common) | Corporate | United States | USD |
| 11 | ERASCA INC | US29479A1088 | 29479A108 | 0.927% | $4.6M | Equity (common) | Corporate | United States | USD |
| 12 | TWIST BIOSCIENCE CORP Twist Bioscience Corporation COM USD0.00001 | US90184D1000 | 90184D100 | 0.922% | $4.6M | Equity (common) | Corporate | United States | USD |
| 13 | KYMERA THERAPEUTICS INC Kymera Therapeutics Inc COM | US5015751044 | 501575104 | 0.902% | $4.5M | Equity (common) | Corporate | United States | USD |
| 14 | SPYRE THERAPEUTICS INC | US00773J2024 | 00773J202 | 0.894% | $4.4M | Equity (common) | Corporate | United States | USD |
| 15 | REVOLUTION MEDICINES INC Revolution Medicines Inc COM | US76155X1000 | 76155X100 | 0.888% | $4.4M | Equity (common) | Corporate | United States | USD |
| 16 | CG ONCOLOGY INC | US1569441009 | 156944100 | 0.885% | $4.4M | Equity (common) | Corporate | United States | USD |
| 17 | PROTAGONIST THERAPEUTICS INC Protagonist Therapeutics Inc COM USD0.00001 | US74366E1029 | 74366E102 | 0.882% | $4.4M | Equity (common) | Corporate | United States | USD |
| 18 | PRAXIS PRECISION MEDICINES INC | US74006W2070 | 74006W207 | 0.873% | $4.3M | Equity (common) | Corporate | United States | USD |
| 19 | REGENERON PHARMACEUTICALS INC Regeneron Pharmaceuticals, Inc. COM USD0.001 | US75886F1075 | 75886F107 | 0.865% | $4.3M | Equity (common) | Corporate | United States | USD |
| 20 | COGENT BIOSCIENCES INC Cogent Biosciences Inc. COM | US19240Q2012 | 19240Q201 | 0.847% | $4.2M | Equity (common) | Corporate | United States | USD |
| 21 | NATERA INC Natera Incorporation COM USD0.0001 | US6323071042 | 632307104 | 0.844% | $4.2M | Equity (common) | Corporate | United States | USD |
| 22 | ARROWHEAD PHARMACEUTICALS INC Arrowhead Pharmaceuticals Inc COM USD0.001 | US04280A1007 | 04280A100 | 0.817% | $4.0M | Equity (common) | Corporate | United States | USD |
| 23 | TRAVERE THERAPEUTICS INC Travere Therapeutics Inc COM | US89422G1076 | 89422G107 | 0.816% | $4.0M | Equity (common) | Corporate | United States | USD |
| 24 | ROIVANT SCIENCES LTD | BMG762791017 | G76279101 | 0.815% | $4.0M | Equity (common) | Corporate | Bermuda | USD |
| 25 | RELAY THERAPEUTICS INC Relay Therapeutics Inc COM | US75943R1023 | 75943R102 | 0.814% | $4.0M | Equity (common) | Corporate | United States | USD |
| 26 | MODERNA INC Moderna Inc COM USD0.0001 | US60770K1079 | 60770K107 | 0.814% | $4.0M | Equity (common) | Corporate | United States | USD |
| 27 | VAXCYTE INC Vaxcyte Inc COM | US92243G1085 | 92243G108 | 0.813% | $4.0M | Equity (common) | Corporate | United States | USD |
| 28 | BRIDGEBIO PHARMA INC Bridgebio Pharma Inc COM USD0.001 | US10806X1028 | 10806X102 | 0.811% | $4.0M | Equity (common) | Corporate | United States | USD |
| 29 | HALOZYME THERAPEUTICS INC Halozyme Therapeutics Inc COM USD0.001 | US40637H1095 | 40637H109 | 0.799% | $4.0M | Equity (common) | Corporate | United States | USD |
| 30 | RHYTHM PHARMACEUTICALS INC Rhythm Pharmaceuticals Inc COM USD0.001 | US76243J1051 | 76243J105 | 0.790% | $3.9M | Equity (common) | Corporate | United States | USD |
| 31 | CYTOKINETICS INC Cytokinetics Inc COM USD0.001 | US23282W6057 | 23282W605 | 0.785% | $3.9M | Equity (common) | Corporate | United States | USD |
| 32 | VIKING THERAPEUTICS INC | US92686J1060 | 92686J106 | 0.781% | $3.9M | Equity (common) | Corporate | United States | USD |
| 33 | AMGEN INC Amgen Inc. COM USD0.0001 | US0311621009 | 031162100 | 0.779% | $3.8M | Equity (common) | Corporate | United States | USD |
| 34 | INCYTE CORP Incyte Corporation. COM USD0.001 | US45337C1027 | 45337C102 | 0.774% | $3.8M | Equity (common) | Corporate | United States | USD |
| 35 | MIRUM PHARMACEUTICALS INC Mirum Pharmaceuticals Inc. COM USD0.0001 | US6047491013 | 604749101 | 0.769% | $3.8M | Equity (common) | Corporate | United States | USD |
| 36 | ALKERMES PLC Alkermes PLC COM USD0.01 | IE00B56GVS15 | G01767105 | 0.763% | $3.8M | Equity (common) | Corporate | Ireland | USD |
| 37 | TG THERAPEUTICS INC TG Therapeutics Inc COM USD0.001 | US88322Q1085 | 88322Q108 | 0.762% | $3.8M | Equity (common) | Corporate | United States | USD |
| 38 | ABBVIE INC AbbVie Inc. COM USD0.01 | US00287Y1091 | 00287Y109 | 0.761% | $3.8M | Equity (common) | Corporate | United States | USD |
| 39 | VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Incorporated COM USD0.01 | US92532F1003 | 92532F100 | 0.747% | $3.7M | Equity (common) | Corporate | United States | USD |
| 40 | KRYSTAL BIOTECH INC Krystal Biotech Inc COM USD0.00001 | US5011471027 | 501147102 | 0.745% | $3.7M | Equity (common) | Corporate | United States | USD |
| 41 | INSMED INC Insmed Inc COM USD0.01 | US4576693075 | 457669307 | 0.733% | $3.6M | Equity (common) | Corporate | United States | USD |
| 42 | SCHOLAR ROCK HOLDING CORP | US80706P1030 | 80706P103 | 0.732% | $3.6M | Equity (common) | Corporate | United States | USD |
| 43 | GILEAD SCIENCES INC Gilead Sciences, Inc. COM USD0.001 | US3755581036 | 375558103 | 0.732% | $3.6M | Equity (common) | Corporate | United States | USD |
| 44 | BIOMARIN PHARMACEUTICAL INC Biomarin Pharmaceutical Inc. COM USD0.001 | US09061G1013 | 09061G101 | 0.729% | $3.6M | Equity (common) | Corporate | United States | USD |
| 45 | UNIQURE NV | NL0010696654 | N90064101 | 0.717% | $3.5M | Equity (common) | Corporate | Netherlands | USD |
| 46 | DYNE THERAPEUTICS INC | US26818M1080 | 26818M108 | 0.717% | $3.5M | Equity (common) | Corporate | United States | USD |
| 47 | BIOGEN INC Biogen Inc COM USD0.0005 | US09062X1037 | 09062X103 | 0.713% | $3.5M | Equity (common) | Corporate | United States | USD |
| 48 | NEUROCRINE BIOSCIENCES INC Neurocrine Biosciences Inc COM USD0.001 | US64125C1099 | 64125C109 | 0.708% | $3.5M | Equity (common) | Corporate | United States | USD |
| 49 | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Not reported | Not reported | 0.707% | $3.5M | Other derivatives | Other | United States | USD |
| 50 | ACADIA PHARMACEUTICALS INC Acadia Pharmaceuticals Inc COM USD0.0001 | US0042251084 | 004225108 | 0.705% | $3.5M | Equity (common) | Corporate | United States | USD |
| 51 | EXELIXIS INC Exelixis, Inc. COM USD0.001 | US30161Q1040 | 30161Q104 | 0.688% | $3.4M | Equity (common) | Corporate | United States | USD |
| 52 | IMMUNOVANT INC Immunovant Inc COM | US45258J1025 | 45258J102 | 0.682% | $3.4M | Equity (common) | Corporate | United States | USD |
| 53 | MADRIGAL PHARMACEUTICALS INC Madrigal Pharmaceuticals Inc USD0.0001 | US5588681057 | 558868105 | 0.677% | $3.3M | Equity (common) | Corporate | United States | USD |
| 54 | GRAIL INC | US3847471014 | 384747101 | 0.670% | $3.3M | Equity (common) | Corporate | United States | USD |
| 55 | CELCUITY INC | US15102K1007 | 15102K100 | 0.668% | $3.3M | Equity (common) | Corporate | United States | USD |
| 56 | SUMMIT THERAPEUTICS INC | US86627T1088 | 86627T108 | 0.665% | $3.3M | Equity (common) | Corporate | United States | USD |
| 57 | CRISPR THERAPEUTICS AG CRISPR Therapeutics AG COM CHF0.03 | CH0334081137 | H17182108 | 0.663% | $3.3M | Equity (common) | Corporate | Switzerland | USD |
| 58 | UNITED THERAPEUTICS CORP United Therapeutics Corporation COM USD0.01 | US91307C1027 | 91307C102 | 0.649% | $3.2M | Equity (common) | Corporate | United States | USD |
| 59 | PTC THERAPEUTICS INC PTC Therapeutics, Inc. COM USD0.001 | US69366J2006 | 69366J200 | 0.633% | $3.1M | Equity (common) | Corporate | United States | USD |
| 60 | ULTRAGENYX PHARMACEUTICAL INC Ultragenyx Pharmaceuticals Inc COM USD0.001 | US90400D1081 | 90400D108 | 0.626% | $3.1M | Equity (common) | Corporate | United States | USD |
| 61 | IMMUNITYBIO INC | US45256X1037 | 45256X103 | 0.614% | $3.0M | Equity (common) | Corporate | United States | USD |
| 62 | SELLAS LIFE SCIENCES GROUP INC | US81642T2096 | 81642T209 | 0.594% | $2.9M | Equity (common) | Corporate | United States | USD |
| 63 | BEAM THERAPEUTICS INC Beam Therapeutics Incorporation COM | US07373V1052 | 07373V105 | 0.591% | $2.9M | Equity (common) | Corporate | United States | USD |
| 64 | BIOCRYST PHARMACEUTICALS INC BioCryst Pharmaceuticals Inc. COM USD0.01 | US09058V1035 | 09058V103 | 0.590% | $2.9M | Equity (common) | Corporate | United States | USD |
| 65 | VERA THERAPEUTICS INC | US92337R1014 | 92337R101 | 0.583% | $2.9M | Equity (common) | Corporate | United States | USD |
| 66 | IDEAYA BIOSCIENCES INC IDEAYA Biosciences Inc. COM USD0.0001 | US45166A1025 | 45166A102 | 0.563% | $2.8M | Equity (common) | Corporate | United States | USD |
| 67 | DENALI THERAPEUTICS INC Denali Therapeutics Inc COM USD0.01 | US24823R1059 | 24823R105 | 0.548% | $2.7M | Equity (common) | Corporate | United States | USD |
| 68 | TANGO THERAPEUTICS INC | US87583X1090 | 87583X109 | 0.539% | $2.7M | Equity (common) | Corporate | United States | USD |
| 69 | ARCUTIS BIOTHERAPEUTICS INC | US03969K1088 | 03969K108 | 0.537% | $2.7M | Equity (common) | Corporate | United States | USD |
| 70 | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Not reported | Not reported | -0.536% | -$2.7M | Other derivatives | Other | United States | USD |
| 71 | CELLDEX THERAPEUTICS INC Celldex Therapeutics Inc. COM USD0.001(POST REV SPLT | US15117B2025 | 15117B202 | 0.528% | $2.6M | Equity (common) | Corporate | United States | USD |
| 72 | VIRIDIAN THERAPEUTICS INC Viridian Therapeutics Inc COM | US92790C1045 | 92790C104 | 0.509% | $2.5M | Equity (common) | Corporate | United States | USD |
| 73 | S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | Not reported | Not reported | 0.506% | $2.5M | Other derivatives | Other | United States | USD |
| 74 | DISC MEDICINE INC | US2546041011 | 254604101 | 0.506% | $2.5M | Equity (common) | Corporate | United States | USD |
| 75 | ARCUS BIOSCIENCES INC Arcus Biosciences Inc. COM USD0.0001 | US03969F1093 | 03969F109 | 0.500% | $2.5M | Equity (common) | Corporate | United States | USD |
| 76 | MINERALYS THERAPEUTICS INC | US6031701013 | 603170101 | 0.493% | $2.4M | Equity (common) | Corporate | United States | USD |
| 77 | IONIS PHARMACEUTICALS INC Ionis Pharmaceuticals, Inc. COM USD0.001 | US4622221004 | 462222100 | 0.482% | $2.4M | Equity (common) | Corporate | United States | USD |
| 78 | ALNYLAM PHARMACEUTICALS INC Alnylam Pharmaceuticals Inc. COM USD0.01 | US02043Q1076 | 02043Q107 | 0.482% | $2.4M | Equity (common) | Corporate | United States | USD |
| 79 | VERACYTE INC Veracyte Inc COM USD0.001 | US92337F1075 | 92337F107 | 0.475% | $2.3M | Equity (common) | Corporate | United States | USD |
| 80 | IMMUNOME INC | US45257U1088 | 45257U108 | 0.468% | $2.3M | Equity (common) | Corporate | United States | USD |
| 81 | SYNDAX PHARMACEUTICALS INC Syndax Pharmaceuticals Inc. COM USD0.0001 | US87164F1057 | 87164F105 | 0.461% | $2.3M | Equity (common) | Corporate | United States | USD |
| 82 | RECURSION PHARMACEUTICALS INC Recursion Pharmaceuticals Inc CL A | US75629V1044 | 75629V104 | 0.455% | $2.3M | Equity (common) | Corporate | United States | USD |
| 83 | SAREPTA THERAPEUTICS INC Sarepta Therapeutics Inc COM USD0.0001 | US8036071004 | 803607100 | 0.454% | $2.2M | Equity (common) | Corporate | United States | USD |
| 84 | ADMA BIOLOGICS INC Adma Biologics Inc COM USD0.0001 | US0008991046 | 000899104 | 0.452% | $2.2M | Equity (common) | Corporate | United States | USD |
| 85 | KODIAK SCIENCES INC | US50015M1099 | 50015M109 | 0.427% | $2.1M | Equity (common) | Corporate | United States | USD |
| 86 | INTELLIA THERAPEUTICS INC Intellia Therapeutics Inc COM USD0.0001 | US45826J1051 | 45826J105 | 0.421% | $2.1M | Equity (common) | Corporate | United States | USD |
| 87 | AGIOS PHARMACEUTICALS INC Agios Pharmaceuticals Inc COM USD0.001 | US00847X1046 | 00847X104 | 0.413% | $2.0M | Equity (common) | Corporate | United States | USD |
| 88 | IOVANCE BIOTHERAPEUTICS INC Iovance Biotherapeutics Inc COM USD0.000041666 | US4622601007 | 462260100 | 0.405% | $2.0M | Equity (common) | Corporate | United States | USD |
| 89 | NURIX THERAPEUTICS INC | US67080M1036 | 67080M103 | 0.392% | $1.9M | Equity (common) | Corporate | United States | USD |
| 90 | PALVELLA THERAPEUTICS INC | US6979471090 | 697947109 | 0.391% | $1.9M | Equity (common) | Corporate | United States | USD |
| 91 | NOVAVAX INC | US6700024010 | 670002401 | 0.378% | $1.9M | Equity (common) | Corporate | United States | USD |
| 92 | VERICEL CORP Vericel Corporation COM NPV | US92346J1088 | 92346J108 | 0.377% | $1.9M | Equity (common) | Corporate | United States | USD |
| 93 | BIOHAVEN LTD Biohaven Ltd COM NPV | VGG1110E1079 | G1110E107 | 0.352% | $1.7M | Equity (common) | Corporate | British Virgin Islands | USD |
| 94 | CAREDX INC Caredx Inc COM USD0.001 | US14167L1035 | 14167L103 | 0.344% | $1.7M | Equity (common) | Corporate | United States | USD |
| 95 | STOKE THERAPEUTICS INC | US86150R1077 | 86150R107 | 0.312% | $1.5M | Equity (common) | Corporate | United States | USD |
| 96 | PRECIGEN INC | US74017N1054 | 74017N105 | 0.305% | $1.5M | Equity (common) | Corporate | United States | USD |
| 97 | TYRA BIOSCIENCES INC | US90240B1061 | 90240B106 | 0.305% | $1.5M | Equity (common) | Corporate | United States | USD |
| 98 | VIR BIOTECHNOLOGY INC VIR Biotechnology Inc COM | US92764N1028 | 92764N102 | 0.294% | $1.5M | Equity (common) | Corporate | United States | USD |
| 99 | ZENAS BIOPHARMA INC | US98937L1052 | 98937L105 | 0.292% | $1.4M | Equity (common) | Corporate | United States | USD |
| 100 | ANAPTYSBIO INC | US0327241065 | 032724106 | 0.288% | $1.4M | Equity (common) | Corporate | United States | USD |